OCT1, acting in the liver and intestinal cells, is important for metformin pharmacokinetics and therapeutic efficacy, and could be involved in 80-fold variability of steady-state metformin concentration reported in T2D patients [46]. The gene discussed is SLC22A1; the disease is type 2 diabetes mellitus.